Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences
NCT01355185 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2014-10-03
Summary
There are substantial uncertainties with contemporary seed placement techniques in prostate brachytherapy, particularly with the impact of seed movement after an implant due to edema and migration of seeds in the prostate and peri-prostatic tissues. This study will accrue 20 patients undergoing prostate brachytherapy implants and perform serial CT and MRI scans at specified intervals (pre-operatively, day 0, day 3, day 10 and day 28) to characterize these phenomena.
Conditions
Sponsors & Collaborators
-
Canadian Association of Radiation Oncology
collaborator INDUSTRY - collaborator INDUSTRY
-
AHS Cancer Control Alberta
lead OTHER
Principal Investigators
-
Nawaid Usmani, MD, FRCPC · University of Alberta
-
Ronald Sloboda, PhD · University of Alberta
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate
NCT01174017 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer
NCT00496249 ·Status: COMPLETED
-
C-arm Cone-beam CT in Prostate Brachytherapy
NCT02322931 ·Status: UNKNOWN ·Phase: NA
-
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
NCT00129025 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
NCT00621413 ·Status: WITHDRAWN
-
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
NCT00681694 ·Status: UNKNOWN
-
Influence of Prostate Cancer Radiation on Aging
NCT04321187 ·Status: COMPLETED
-
LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients
NCT02895854 ·Status: UNKNOWN ·Phase: NA
-
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
NCT00643617 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.
NCT04535908 ·Status: TERMINATED ·Phase: NA
-
Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy
NCT01936883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients
NCT05354427 ·Status: COMPLETED
-
Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
NCT00122265 ·Status: TERMINATED
-
LDR vs. HDR Brachytherapy for Prostate Cancer
NCT03426748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Medical and Economic Evaluation for Intermediate-risk Prostate Cancer
NCT02271659 ·Status: UNKNOWN ·Phase: NA
-
US-CT Fusion for Post Implant Dosimetry
NCT03692104 ·Status: COMPLETED
-
Prostate Cancer Stereotactic Radiotherapy
NCT02319239 ·Status: COMPLETED ·Phase: NA
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
NCT00499421 ·Status: COMPLETED
-
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
NCT05344235 ·Status: RECRUITING
-
CMT-07-08: The PROstate Bed Evaluation Study
NCT00763152 ·Status: COMPLETED
-
Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System
NCT05354440 ·Status: ACTIVE_NOT_RECRUITING
-
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
NCT02077335 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007 ·Status: RECRUITING ·Phase: PHASE3
-
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NCT05361902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA